Toll Free: 1-888-928-9744
Published: Feb, 2016 | Pages:
26 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Thelial Technologies S.A. - Product Pipeline Review - 2016 Summary Global Markets Direct's, 'Thelial Technologies S.A. - Product Pipeline Review - 2016', provides an overview of the Thelial Technologies S.A.'s pharmaceutical research and development focus. The report provides comprehensive information on the therapeutics under development by Thelial Technologies S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis. The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data. Scope - The report provides a snapshot of the pipeline therapeutic landscape of Thelial Technologies S.A. - The report provides overview of Thelial Technologies S.A. including its business description, key facts, and locations and subsidiaries - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report assesses Thelial Technologies S.A.'s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type - The report features Thelial Technologies S.A.'s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects Reasons to Buy - Evaluate Thelial Technologies S.A.'s strategic position with total access to detailed information on its product pipeline - Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Thelial Technologies S.A. - Identify potential new clients or partners in the target demographic - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Thelial Technologies S.A.'s pipeline depth and focus of pipeline therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and Scope
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Thelial Technologies S.A. Snapshot 5 Thelial Technologies S.A. Overview 5 Key Information 5 Key Facts 5 Thelial Technologies S.A. - Research and Development Overview 6 Key Therapeutic Areas 6 Thelial Technologies S.A. - Pipeline Review 8 Pipeline Products by Stage of Development 8 Pipeline Products - Monotherapy 9 Thelial Technologies S.A. - Pipeline Products Glance 10 Thelial Technologies S.A. - Early Stage Pipeline Products 10 Discovery Products/Combination Treatment Modalities 10 Thelial Technologies S.A. - Unknown Stage Pipeline Products 11 Unknown Products/Combination Treatment Modalities 11 Thelial Technologies S.A. - Drug Profiles 12 The-103 12 Product Description 12 Mechanism of Action 12 R&D Progress 12 The-104 13 Product Description 13 Mechanism of Action 13 R&D Progress 13 The-105 14 Product Description 14 Mechanism of Action 14 R&D Progress 14 The-106 15 Product Description 15 Mechanism of Action 15 R&D Progress 15 The-107 16 Product Description 16 Mechanism of Action 16 R&D Progress 16 The-108 17 Product Description 17 Mechanism of Action 17 R&D Progress 17 The-109 18 Product Description 18 Mechanism of Action 18 R&D Progress 18 The-110 19 Product Description 19 Mechanism of Action 19 R&D Progress 19 The-111 20 Product Description 20 Mechanism of Action 20 R&D Progress 20 The-124 21 Product Description 21 Mechanism of Action 21 R&D Progress 21 Thelial Technologies S.A. - Pipeline Analysis 22 Thelial Technologies S.A. - Pipeline Products by Route of Administration 22 Thelial Technologies S.A. - Pipeline Products by Molecule Type 23 Thelial Technologies S.A. - Locations And Subsidiaries 24 Head Office 24 Appendix 25 Methodology 25 Coverage 25 Secondary Research 25 Primary Research 25 Expert Panel Validation 25 Contact Us 25 Disclaimer 26
List of Tables Thelial Technologies S.A., Key Information 5 Thelial Technologies S.A., Key Facts 5 Thelial Technologies S.A. - Pipeline by Indication, 2016 7 Thelial Technologies S.A. - Pipeline by Stage of Development, 2016 8 Thelial Technologies S.A. - Monotherapy Products in Pipeline, 2016 9 Thelial Technologies S.A. - Discovery, 2016 10 Thelial Technologies S.A. - Unknown, 2016 11 Thelial Technologies S.A. - Pipeline by Route of Administration, 2016 22 Thelial Technologies S.A. - Pipeline by Molecule Type, 2016 23
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.